160 related articles for article (PubMed ID: 26081024)
21. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
[TBL] [Abstract][Full Text] [Related]
22. Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism.
Marketou ME; Kintsurashvili E; Androulakis NE; Kontaraki J; Alexandrakis MG; Gavras I; Vardas PE; Gavras H
Int J Cardiol; 2013 Oct; 168(3):2561-6. PubMed ID: 23582690
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation.
Pavanetto M; Zarpellon A; Giacomini D; Galletti P; Quintavalla A; Cainelli G; Folda A; Scutari G; Deana R
Platelets; 2007 Aug; 18(5):357-64. PubMed ID: 17654305
[TBL] [Abstract][Full Text] [Related]
24. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
[TBL] [Abstract][Full Text] [Related]
25. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M
Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biological activity of phenolic fraction from roots of Alhagi maurorum with properties of commercial phenolic extracts and resveratrol.
Olas B; Hamed AI; Oleszek W; Stochmal A
Platelets; 2015; 26(8):788-94. PubMed ID: 25901460
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
[TBL] [Abstract][Full Text] [Related]
29. Free radical scavenging and skin penetration of troxerutin and vitamin derivatives.
Kessler M; Ubeaud G; Walter T; Sturm F; Jung L
J Dermatolog Treat; 2002 Sep; 13(3):133-41. PubMed ID: 12227877
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid.
Toliopoulos IK; Simos YV; Daskalou TA; Verginadis II; Evangelou AM; Karkabounas SC
Indian J Exp Biol; 2011 Dec; 49(12):904-8. PubMed ID: 22403863
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
Dell'Agli M; Maschi O; Galli GV; Fagnani R; Dal Cero E; Caruso D; Bosisio E
Br J Nutr; 2008 May; 99(5):945-51. PubMed ID: 17927845
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinase blockers: new platelet activation inhibitors.
Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
[TBL] [Abstract][Full Text] [Related]
34. Sitagliptin: anti-platelet effect in diabetes and healthy volunteers.
Gupta AK; Verma AK; Kailashiya J; Singh SK; Kumar N
Platelets; 2012; 23(8):565-70. PubMed ID: 22950787
[TBL] [Abstract][Full Text] [Related]
35. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
36. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
37. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of blood platelet adhesion and secretion by different phenolics from Yucca schidigera Roezl. bark.
Olas B; Wachowicz B; Stochmal A; Oleszek W
Nutrition; 2005 Feb; 21(2):199-206. PubMed ID: 15723749
[TBL] [Abstract][Full Text] [Related]
39. Ascorbyl Stearate Promotes Apoptosis Through Intrinsic Mitochondrial Pathway in HeLa Cancer Cells.
Mane SD; Thoh M; Sharma D; Sandur SK; Naidu KA
Anticancer Res; 2016 Dec; 36(12):6409-6417. PubMed ID: 27919962
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol, a phenolic antioxidant with effects on blood platelet functions.
Olas B; Wachowicz B
Platelets; 2005 Aug; 16(5):251-60. PubMed ID: 16011975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]